New long-acting androgens

被引:3
|
作者
Gooren, LJ [1 ]
机构
[1] VU Univ Med Ctr, Dept Endocrinol, Sect Androl, NL-1007 MB Amsterdam, Netherlands
关键词
testosterone; replacement therapy; parenteral androgen; testosterone implant; aging male;
D O I
10.1007/s00345-003-0364-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Testosterone substitution treatment aims to replace physiological actions of endogenous testosterone by steadily maintaining physiological blood levels of testosterone. The underlying conditions rendering androgen replacement necessary are usually irreversible. The consequence is that almost life-long androgen replacement is required. Patient compliance with life-long androgen replacement depends on convenient pharmaceutical formulations ensuring continuity of androgen replacement. Therefore, they must be convenient in usage with a relative independence of medical services. In elderly man, safety of androgen replacement therapy is a concern but in younger subjects (below the age of 50 years) side effects of androgens are usually minimal. For them, long-acting testosterone preparations are well suited. Testosterone implants generate, depending on the dose of implants, 3-6 months of normal plasma testosterone. This method requires minor surgery. Injectable testosterone undecanoate maintains plasma testosterone in the normal range for 12 weeks.
引用
收藏
页码:306 / 310
页数:5
相关论文
共 50 条
  • [21] NEW, LONG-ACTING, POTENT BRADYKININ ANTAGONISTS
    LEMBECK, F
    GRIESBACHER, T
    ECKHARDT, M
    HENKE, S
    BREIPOHL, G
    KNOLLE, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (02) : 297 - 304
  • [22] NEW LONG-ACTING ANTICHOLINERGIC IN GASTRODUODENAL PATHOLOGY
    PERGOLA, F
    MEDECINE & CHIRURGIE DIGESTIVES, 1977, 6 (02): : 105 - 107
  • [23] New long-acting β2-agonists
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (09) : 1385 - 1388
  • [24] TRIAL OF A NEW LONG-ACTING ANTIANGINAL DRUG
    SAINTPIE.A
    COEUR ET MEDECINE INTERNE, 1973, 12 (01): : 155 - 161
  • [25] FORMOTEROL, A NEW LONG-ACTING BRONCHODILATOR FOR INHALATION
    ARVIDSSON, P
    LARSSON, S
    LOFDAHL, CG
    MELANDER, B
    WAHLANDER, L
    SVEDMYR, N
    EUROPEAN RESPIRATORY JOURNAL, 1989, 2 (04) : 325 - 330
  • [26] New Addition to Long-Acting Reversible Contraception
    Raphaelidis, Leia
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (03): : 377 - 378
  • [27] OPEN STUDY WITH A NEW LONG-ACTING NEUROLEPTIC
    FLEISCHHAUER, J
    ANGST, J
    PADRUTT, A
    VETTER, P
    ACTIVITAS NERVOSA SUPERIOR, 1973, 15 (02): : 85 - 86
  • [28] BASIC PHARMACOLOGY OF NEW LONG-ACTING SYMPATHOMIMETICS
    LOFDAHL, CG
    LUNG, 1990, 168 : 18 - 21
  • [29] WHY ARE LONG-ACTING BETA-ADRENOCEPTOR AGONISTS LONG-ACTING
    ANDERSON, GP
    LINDEN, A
    RABE, KF
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (03) : 569 - 578
  • [30] LONG-ACTING NEUROLEPTICS
    CAPPADORO, R
    LEMOINE, P
    COROT, P
    PSYCHOPATHOLOGIE AFRICAINE, 1981, 17 (1-3): : 505 - 510